Estrogen Replacement Therapy
Research News and Information

Saturday, November 21, 2009

Genetic variation in the progesterone receptor and metabolism pathways and hormone therapy in relation to breast cancer risk.

19 Oct 2009 The relevance of progesterone to breast carcinogenesis is highlighted by evidence indicating that use of combined estrogen-progesterone therapy (EPT) is more strongly related to breast cancer risk than is use of unopposed estrogen therapy. However, ... Read more...

Parity and age at first childbirth in relation to the risk of different breast cancer subgroups.

13 Oct 2009 The aim of the present study was to examine parity and age at first childbirth, in relation to the risk of specific breast cancer subgroups. A prospective cohort, The Malmö Diet and Cancer Study, including 17,035 women were followed with linkage to ... Read more...

Incidence and mortality of hip fractures in the United States.

12 Oct 2009 CONTEXT: Understanding the incidence and subsequent mortality following hip fracture is essential to measuring population health and the value of improvements in health care. OBJECTIVE: To examine trends in hip fracture incidence and resulting ... Read more...

Latest indexed articles for 'Estrogen Replacement Therapy'

These are the very latest articles for this heading:

• Postmenopausal hormone therapy and regional brain volumes: the WHIMS-MRI study. Nov 2009
• Genetic variation in the progesterone receptor and metabolism pathways and hormone therapy in relation to breast cancer risk. 19 Oct 2009
• Parity and age at first childbirth in relation to the risk of different breast cancer subgroups. 13 Oct 2009
• Incidence and mortality of hip fractures in the United States. 12 Oct 2009
• New-onset breast tenderness after initiation of estrogen plus progestin therapy and breast cancer risk. 10 Oct 2009
• Side effects of phytoestrogens: a meta-analysis of randomized trials. 29 Sep 2009
• +331G/A variant in the progesterone receptor gene, postmenopausal hormone use and risk of breast cancer. 29 Sep 2009
• Another nail in the coffin for hormone-replacement therapy? 16 Sep 2009
• Oestrogen plus progestin and lung cancer in postmenopausal women (Women's Health Initiative trial): a post-hoc analysis of a randomised controlled trial. 16 Sep 2009
• Estrogen-progestagen menopausal hormone therapy and breast cancer: does delay from menopause onset to treatment initiation influence risks? 12 Sep 2009
• Combined hormone therapy at menopause and breast cancer: a warning--short-term use increases risk. 12 Sep 2009
• Short-term effects of parathyroid hormone on rat lumbar vertebrae. 30 Aug 2009
• Total estrogen time and obstructive coronary disease in women: insights from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE). 30 Aug 2009
• Ambulatory arterial stiffness index in Turner syndrome: the impact of sex hormone replacement therapy. 30 Aug 2009
• Neuroprotective effects of estrogen therapy for cognitive and neurobiological profiles of monkey models of menopause. 30 Aug 2009
• The effects of hormone therapy decision support for women with mobility impairments. 30 Aug 2009
• Postmenopausal hormone therapy and the risk of cardiovascular disease. 30 Aug 2009
• Use of hormone replacement therapy and the risk of colorectal cancer. 22 Aug 2009
• The value of IGF1 estimation in adults with GH deficiency. 12 Aug 2009
• GH replacement in adults: interactions with other pituitary hormone deficiencies and replacement therapies. 12 Aug 2009

See a longer list of these articles.

Technical information about 'Estrogen Replacement Therapy'

Definition: The use of hormonal agents with estrogen-like activity in postmenopausal or other estrogen-deficient women to alleviate effects of hormone deficiency, such as vasomotor symptoms, DYSPAREUNIA, and progressive development of OSTEOPOROSIS. This may also include the use of progestational agents in combination therapy.

Descriptor UI: D015914

Alternative terms: Estrogen Replacement Therapy; Estrogen Replacement Therapies; Replacement Therapies, Estrogen; Therapies, Estrogen Replacement; Therapy, Estrogen Replacement; Replacement Therapy, Estrogen; Estrogen Replacement; Estrogen Replacements; Replacements, Estrogen; Replacement, Estrogen; Postmenopausal Hormone Replacement Therapy; Hormone Replacement Therapy, Post-Menopausal; Hormone Replacement Therapy, Post Menopausal; Estrogen Progestin Replacement Therapy; Estrogen Progestin Combination Therapy;

Allowable Qualifiers: adverse effects; classification; economics; history; instrumentation; methods; mortality; nursing; psychology; standards; trends; utilization; veterinary; statistics & numerical data; contraindications; ethics;

Tree Number: E02.319.452.150;

History Note: 90

Technical Notes: coord IM with specific estrogen (IM or NIM) and also specific progestational agent (IM or NIM) if pertinent; check tag FEMALE; DF: ESTROGEN REPLACE